Melissa Leneis - 17 May 2024 Form 4 Insider Report for QUAKER CHEMICAL CORP (KWR)

Role
EVP, CHRO
Signature
Victoria K. Gehris, Attorney-in-Fact for Melissa Leneis
Issuer symbol
KWR
Transactions as of
17 May 2024
Net transactions value
-$158,317
Form type
4
Filing time
21 May 2024, 16:11:04 UTC
Previous filing
19 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KWR Common Stock Sale $77,678 -400 -13% $194.20 2,609 17 May 2024 Direct
transaction KWR Common Stock Options Exercise $230,371 +1,618 +62% $142.38 4,227 17 May 2024 Direct
transaction KWR Common Stock Sale $311,010 -1,618 -38% $192.22 2,609 17 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KWR Employee Stock Option (right to buy) Options Exercise $0 -1,618 -53% $0.000000 1,411 17 May 2024 Common Stock 1,618 $142.38 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.9907 to $192.35, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2 The options for this grant vest in three annual installments: 1,410 shares on March 16, 2023; 1,410 shares on March 16, 2024; and 1,411 shares on March 16, 2025.